Radius Health Announces Latest 2019 Medicare Part D Coverage for TYMLOS (abaloparatide) Injection Pharmaceutical Investing
Precipio Launches HemeScreen, a Disruptive, Proprietary Molecular Test for Hematologic Cancers Medical Device Investing
Naturally Splendid Extends LOI With CROP and Will Now Infuse CROP’s “CannaDrink” Functional Beverages With HempOmega™ Cannabis Investing News
Phivida Comments on the Removal of CBD From U.S. DEA Schedule 1 and Announces Share Issuance Cannabis Investing News
Melinta Therapeutics Publishes Complete Results from Phase III TANGO 2 Study of Vabomere Pharmaceutical Investing
Rexahn Pharmaceuticals Presents Preliminary Safety and Efficacy Data From Ongoing Phase 2a Clinical Trial Pharmaceutical Investing
Clementia Initiates Phase 1 Clinical Trial of Palovarotene Eye Drop Formulation in Healthy Volunteers Pharmaceutical Investing
